Akouos
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Akouos and buy or sell other stocks, ETFs, and their options commission-free!About AKUS
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.
CEOEmmanuel J. Simons, PhD, MBA
CEOEmmanuel J. Simons, PhD, MBA
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2016
Founded2016
Employees—
Employees—
AKUS Key Statistics
Market cap491.02M
Market cap491.02M
Price-Earnings ratio-5.06
Price-Earnings ratio-5.06
Dividend yield—
Dividend yield—
Average volume854.20K
Average volume854.20K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.60
52 Week high$13.60
52 Week low$2.32
52 Week low$2.32